Dr. Barbara Krebs-Pohl

Dr. Barbara Krebs-PohlDr. Barbara Krebs-Pohl
DB

Dr. Barbara Krebs-Pohl

Chair of the Board at Nykode Therapeutics ASA

Rate
Advertise here

About

Dr. Barbara Krebs-Pohl is a seasoned biotech executive with over 27 years of global experience in R&D, business development, licensing, alliance management, portfolio management, and strategic transformation. She currently serves as Chair of the Board of Nykode Therapeutics ASA and OneChain Immunotherapeutics, and as Managing Director of Viopas Venture Consulting and the Foundation for Stem Cell Therapy and Regenerative Medicine. Her career includes a distinguished 20-year tenure at MorphoSys AG, where she held various leadership roles including Chief Business Officer.
Frequently asked

Who is Dr. Barbara Krebs-Pohl?

Dr. Barbara Krebs-Pohl is a seasoned biotech executive with over 27 years of global experience in R&D, business development, licensing, alliance management, portfolio management, and strategic transformation. She currently serves as Chair of the Board of Nykode Therapeutics ASA and OneChain Immunotherapeutics, and as Managing Director of Viopas Venture Consulting and the Foundation for Stem Cell T…

What is Dr. Barbara Krebs-Pohl's current role?

Dr. Barbara Krebs-Pohl is currently Chair of the Board at Nykode Therapeutics ASA.

Comments

No comments yet. Be the first to share your take.

Profile

About Dr. Barbara Krebs-Pohl

Dr. Barbara Krebs-Pohl is Chair of the Board at Nykode Therapeutics ASA. This profile tracks their companies, funding activity, and news mentions across the AI ecosystem.